0QU747Z
Supplement Upper Femur, Left to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | Q Lower Bones |
| Operation | U Supplement |
| Body Part | 7 Upper Femur, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures in the lower bones add material - a mesh, graft, cement, or synthetic reinforcement - to strengthen or bulk up a bone that is still substantially present, rather than removing or replacing it outright. Typical uses include augmenting a thinning pelvic wall, reinforcing a healing fracture site, or filling a bone defect left after a benign lesion was scraped out.
Patients undergo this kind of procedure when a bone is structurally weak but does not need to be taken out - for example, bone grafting to fill a cavity, cement augmentation in osteoporotic bone before hardware placement, or mesh reinforcement over a thin cortical wall. The goal is to restore mechanical strength and support healing or subsequent hardware fixation, not to replace the bone's own tissue.
Anatomy & Axis Detail
Upper Femur, Left
On the left side, the upper femur, including the head, neck, and proximal shaft, forms the critical load-bearing junction of the hip joint and is a common site of fragility fracture in older adults due to its concentrated mechanical stress and often reduced bone density. Supplementation here uses bone graft, cement, or synthetic augmentation material to reinforce a region weakened by osteoporosis, tumor involvement, or bone loss surrounding a failing implant, restoring enough structural strength to support subsequent fixation or to prevent further collapse. Because the proximal femur's blood supply is precarious and closely tied to femoral head viability, procedures here require careful technique, and documentation should confirm the material reinforced existing bone rather than replacing the joint surface.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders need documentation confirming that the patient's own bone structure remained in place and that material was added to reinforce or augment it - autograft, allograft, synthetic bone substitute, or cement all qualify, and the specific substance often drives the correct device value. The material must physically bolster the existing bone rather than simply fill dead space cosmetically.
A common mixup is coding Supplement when the correct root operation is Replacement, which applies only when the material takes over the entire function of a body part that has been made physically absent - if the bone itself was removed and replaced, that's Replacement, not Supplement. Another frequent error is missing a concurrent Excision or Repair code when the graft site was first debrided or an underlying fracture was fixed.